Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. (HKG:1349)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
2.820
+0.030 (1.06%)
Apr 21, 2026, 4:08 PM HKT

HKG:1349 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
7,2537,4696,6028,0577,76713,434
Market Cap Growth
4.12%13.14%-18.06%3.73%-42.18%-14.60%
Enterprise Value
5,9936,2655,4656,8506,42712,106
Last Close Price
2.822.782.442.393.163.42
PE Ratio
--156.1367.3249.7951.31
Forward PE
-22.4622.4622.4622.4622.46
PS Ratio
9.509.798.748.606.669.60
PB Ratio
3.083.172.693.103.055.00
P/TBV Ratio
3.173.272.783.223.135.20
P/FCF Ratio
59.7861.56--88.1373.56
P/OCF Ratio
46.0947.47-102.9841.5740.70
PEG Ratio
-0.690.690.690.690.69
EV/Sales Ratio
7.858.217.247.315.518.65
EV/EBITDA Ratio
--87.7348.1830.4145.55
EV/EBIT Ratio
---80.5949.8360.61
EV/FCF Ratio
49.3951.63--72.9266.29
Debt / Equity Ratio
0.010.010.010.010.060.01
Debt / EBITDA Ratio
--0.310.130.640.14
Debt / FCF Ratio
0.140.14--1.600.21
Net Debt / Equity Ratio
-0.53-0.53-0.45-0.50-0.53-0.54
Net Debt / EBITDA Ratio
10.8010.80-17.70-9.13-6.39-5.44
Net Debt / FCF Ratio
-10.39-10.3917.5042.17-15.32-7.91
Asset Turnover
0.280.280.260.290.360.43
Inventory Turnover
1.761.761.401.762.272.26
Quick Ratio
5.885.886.093.602.983.56
Current Ratio
6.056.056.403.703.073.65
Return on Equity (ROE)
-7.13%-7.13%1.69%4.70%6.18%10.12%
Return on Assets (ROA)
-4.01%-4.01%-0.18%1.65%2.48%3.85%
Return on Invested Capital (ROIC)
-14.94%-14.19%-0.63%6.89%11.02%19.48%
Return on Capital Employed (ROCE)
-7.50%-7.50%-0.30%3.30%5.00%7.20%
Earnings Yield
-2.42%-2.35%0.64%1.49%2.01%1.95%
FCF Yield
1.67%1.62%-0.95%-0.38%1.14%1.36%
Dividend Yield
1.14%-2.18%3.23%2.50%2.51%
Payout Ratio
--234.79%70.10%51.48%24.45%
Buyback Yield / Dilution
---0.23%-0.29%1.29%-5.59%
Total Shareholder Return
1.14%-1.95%2.94%3.80%-3.08%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.